The trial aims to determine and compare the effect of three different single doses of PQ combined with an ACT, dihydroartemisinin-piperaquine (DHA-PPQ), on gametocyte carriage in asymptomatic, malaria-infected, G6PD-normal individuals. The gene discussed is G6PD; the disease is malaria.